France· FR:65028549
SOMAKIT TOC 40 microgrammes, trousse pour préparation radiopharmaceutique
A medicinal product containing édotréotide, registered in France by NOVARTIS EUROPHARM (IRLANDE).
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- ÉDOTRÉOTIDE
- Manufacturer
- NOVARTIS EUROPHARM (IRLANDE)
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- No
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
- cip133400955028857flacon(s) en verre de 40 microgrammes - flacon(s) polycyclooléfine de 1 ml
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Édotréotide in 10 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumSomaKit TOC 40 µgNovartis Europharm
- CzechiaSOMAKIT TOCNovartis Europharm Limited, Dublin
- SpainSOMAKIT TOC 40 MICROGRAMOS EQUIPO DE REACTIVOS PARA PREPARACION RADIOFARMACEUTICANovartis Europharm Limited
- FinlandSomaKit TOCNovartis Europharm Limited
- United KingdomSomaKit TOC 40microgram kit for radiopharmaceutical preparationNovartis Pharmaceuticals UK Ltd
- IcelandSomaKit TOCNovartis Europharm Limited
- NetherlandsSomaKit TOC 40 microgram, Kit voor radiofarmaceutisch preparaatNovartis Europharm Limited
- NorwaySomaKit TOCNovartis Europharm Limited
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Somakit Toc
- Liechtenstein · Somakit Toc
- Norway · Somakit Toc
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f0569ceb-03d3-4230-a979-ddecb7193331 GET /v1/drugs/f0569ceb-03d3-4230-a979-ddecb7193331?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "65028549",
"date_amm": "2016-12-08",
"type_amm": "Procédure centralisée",
"numero_ue": "EU/1/16/1141",
"substance": "ÉDOTRÉOTIDE",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "trousse et trousse pour préparation radiopharmaceutique",
"voies_administration": "intraveineuse",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Oui"
}See everything about édotréotide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.